Progress in cancer mortality, incidence, and survival: a global overview
- PMID: 32740162
- DOI: 10.1097/CEJ.0000000000000594
Progress in cancer mortality, incidence, and survival: a global overview
Abstract
Cancer mortality has declined over the last three decades in most high-income countries reflecting improvements in cancer prevention, diagnosis, and management. However, there are persisting and substantial differences in mortality, incidence, and survival worldwide. In order to provide an up-to-date overview of trends in mortality, incidence, and survival, we retrieved data from high-quality, population-based cancer registries for all cancers and 10 selected cancer sites in six high-income countries and the European Union. We computed age-standardized (world standard population) mortality and incidence rates, and applied joinpoint regression models. Mortality from all cancers and most common cancer sites has declined over the last 25 years, except for the pancreas and lung (in women). The patterns for incidence are less consistent between countries, except for a steady decrease in stomach cancer in both sexes and lung cancer in men. Survival for all cancers and the selected cancer sites increased in all countries, even if there is still a substantial variability. Although overall cancer death rates continue to decline, incidence rates have been levelling off among men and have been moderately increasing among women. These trends reflect changes in cancer risk factors, screening test use, diagnostic practices, and treatment advances. Many cancers can be prevented or treated effectively if they are diagnosed early. Population-based cancer incidence and mortality data can be used to focus efforts to decrease the cancer burden and regularly monitor progress towards cancer control goals.
Similar articles
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
Global Cancer Incidence and Mortality Rates and Trends--An Update.Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):16-27. doi: 10.1158/1055-9965.EPI-15-0578. Epub 2015 Dec 14. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26667886 Review.
-
Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980.Ann Oncol. 2013 Oct;24(10):2657-2671. doi: 10.1093/annonc/mdt301. Epub 2013 Aug 6. Ann Oncol. 2013. PMID: 23921790
-
Common cancers in the elderly.Drugs Aging. 1998 Dec;13(6):467-78. doi: 10.2165/00002512-199813060-00005. Drugs Aging. 1998. PMID: 9883401 Review.
Cited by
-
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer.Sci Rep. 2024 Jan 20;14(1):1778. doi: 10.1038/s41598-024-52153-w. Sci Rep. 2024. PMID: 38245572 Free PMC article.
-
Prevalence of hand-foot syndrome following chemotherapy for colorectal cancer: a systematic review and meta-analysis.Int J Colorectal Dis. 2023 Mar 6;38(1):61. doi: 10.1007/s00384-023-04345-5. Int J Colorectal Dis. 2023. PMID: 36872385
-
A Ductal-Cell-Related Risk Model Integrating Single-Cell and Bulk Sequencing Data Predicts the Prognosis of Patients With Pancreatic Adenocarcinoma.Front Genet. 2022 Jan 3;12:763636. doi: 10.3389/fgene.2021.763636. eCollection 2021. Front Genet. 2022. PMID: 35047000 Free PMC article.
-
The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer.Front Oncol. 2021 Jun 15;11:639745. doi: 10.3389/fonc.2021.639745. eCollection 2021. Front Oncol. 2021. PMID: 34211836 Free PMC article. Review.
-
Retrospective Study of Lung Cancer: Evolution in 16 Years in the Burgos Region.J Clin Med. 2024 Mar 11;13(6):1601. doi: 10.3390/jcm13061601. J Clin Med. 2024. PMID: 38541827 Free PMC article.
References
-
- Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017; 71:96–108
-
- Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, et al. Data from population-based cancer registration for secondary data analysis: methodological challenges and perspectives. Gesundheitswesen. 2020; 82:S62–S71
-
- Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TÅ, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019; 20:1493–1505
-
- Balakrishnan M, George R, Sharma A, Graham DY. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 2017; 19:36
-
- Beral V, Doll R, Hermon C, Peto R, Reeves G; Collaborative Group on Epidemiological Studies of Ovarian C. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008; 371:303–314
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical